Alvilde Maria Ossum1,2, Øyvind Palm3, Milada Cvancarova4, Tomm Bernklev2,5, Jørgen Jahnsen2,6, Bjørn Moum1,2, Marte Lie Høivik1. 1. Department of Gastroenterology, Oslo University Hospital, Oslo, Norway. 2. Institute of Clinical Medicine, University of Oslo, Oslo, Norway. 3. Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway. 4. Faculty of Health Sciences, OsloMet, Oslo, Norway. 5. R&D Department, Vestfold Hospital Trust, Tønsberg, Norway. 6. Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.
Abstract
BACKGROUND: Patients with inflammatory bowel disease (IBD) often suffer from musculoskeletal manifestations. Health-related quality of life (HRQoL) and fatigue are known to be associated with IBD activity and musculoskeletal complaints. The aim of this study was to determine the association between spondyloarthritis, arthralgia, or back pain and the patient-reported outcomes of HRQoL and fatigue in IBD patients 20 years after their diagnosis. METHODS: The IBSEN cohort was followed prospectively for 20 years. At the 20-year follow-up, the patients answered detailed questionnaires regarding rheumatological manifestations, intestinal symptoms, HRQoL, and fatigue. Multiple regression analyses were used to evaluate associations between spondyloarthritis or joint symptoms and HRQoL or fatigue. Sex, IBD diagnosis, and age were included in all the multiple regression models, in addition to other clinically relevant confounders. RESULTS: In total, 441 patients (94%) completed the questionnaires at the 20-year follow-up. The criteria for spondyloarthritis (axial or peripheral) were fulfilled in 158 patients (36%), current back pain during the previous 3 months was reported by 79 patients (18%), and current arthralgia was reported by 178 patients (40%). Current back pain and arthralgia were independently associated with lower HRQoL, higher levels of fatigue, and chronic fatigue. A diagnosis of spondyloarthritis was not associated with reduced HRQoL or fatigue when adjusted for possible confounders. CONCLUSIONS: Current joint symptoms in IBD patients 20 years after diagnosis were associated with poorer HRQoL, higher levels of fatigue, and chronic fatigue, whereas spondyloarthritis did not impact HRQoL or fatigue negatively in this cohort.
BACKGROUND:Patients with inflammatory bowel disease (IBD) often suffer from musculoskeletal manifestations. Health-related quality of life (HRQoL) and fatigue are known to be associated with IBD activity and musculoskeletal complaints. The aim of this study was to determine the association between spondyloarthritis, arthralgia, or back pain and the patient-reported outcomes of HRQoL and fatigue in IBDpatients 20 years after their diagnosis. METHODS: The IBSEN cohort was followed prospectively for 20 years. At the 20-year follow-up, the patients answered detailed questionnaires regarding rheumatological manifestations, intestinal symptoms, HRQoL, and fatigue. Multiple regression analyses were used to evaluate associations between spondyloarthritis or joint symptoms and HRQoL or fatigue. Sex, IBD diagnosis, and age were included in all the multiple regression models, in addition to other clinically relevant confounders. RESULTS: In total, 441 patients (94%) completed the questionnaires at the 20-year follow-up. The criteria for spondyloarthritis (axial or peripheral) were fulfilled in 158 patients (36%), current back pain during the previous 3 months was reported by 79 patients (18%), and current arthralgia was reported by 178 patients (40%). Current back pain and arthralgia were independently associated with lower HRQoL, higher levels of fatigue, and chronic fatigue. A diagnosis of spondyloarthritis was not associated with reduced HRQoL or fatigue when adjusted for possible confounders. CONCLUSIONS: Current joint symptoms in IBDpatients 20 years after diagnosis were associated with poorer HRQoL, higher levels of fatigue, and chronic fatigue, whereas spondyloarthritis did not impact HRQoL or fatigue negatively in this cohort.
Authors: You-Jung Ha; Hyo Jin Kim; Eugene Lee; Ji Hye Park; Young Soo Park; Yun Jong Lee; Yusuhn Kang; Hyuk Yoon Journal: Korean J Intern Med Date: 2021-03-22 Impact factor: 2.884
Authors: Anna Zielińska; Aleksandra Sobolewska-Włodarczyk; Maria Wiśniewska-Jarosińska; Anita Gąsiorowska; Jakub Fichna; Maciej Sałaga Journal: Pharmaceuticals (Basel) Date: 2021-03-22
Authors: Fenna M Jansen; Stephan R Vavricka; Alfons A den Broeder; Elke Mgj de Jong; Frank Hoentjen; Willemijn A van Dop Journal: United European Gastroenterol J Date: 2020-09-14 Impact factor: 4.623